Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 February 2025 | Story Vuyelwa Mbebe | Photo Supplied
Regional Committee SAACHS
The Kovsie Health staff members who also serve on the SAACHS regional committee: Shibashiba Moabelo, Riana Johnson, Sarien de Necker, Theresa de Vries, and Emmerencia Sibanda.

The University of the Free State (UFS) took centre stage at the annual South African Association of Campus Health Services (SAACHS) Conference, held at the Windmill Casino Conference Centre in Bloemfontein from 8 to 10 January 2025. 

The conference was themed ‘Student Centredness’ and brought together representatives from 22 higher education institutions to explore critical issues related to student health and wellness.

SAACHS is a national association comprising tertiary institutions that offer primary and occupational healthcare services on campuses across South Africa. This year’s conference covered a range of pressing topics, including HIV support for students, strategies to assist pregnant students, telehealth collaborations, caregiver self-care, student health-seeking behaviours, food insecurity, and best practices in campus health emergency medical services.

Sr Riana Johnson, Deputy Director of Kovsie Health and regional chair of the Free State and Northern Cape SAACHS committee, emphasised the impact of the UFS’s involvement. “The strong representation of UFS speakers highlighted the strides we have made in campus health services and the invaluable contributions our institution brings to these crucial discussions,” she said.

As key organisers, Johnson and her team – including Sr Sarien de Necker and colleagues from the UFS and the Central University of Technology (CUT) – were instrumental in securing speakers, selecting relevant topics, and managing conference logistics. Their efforts ensured the smooth running of an event that encouraged knowledge-sharing and collaboration among campus health professionals.

“The conference provided a vital platform for networking and exchanging ideas,” Johnson said. “UFS’s active participation helped strengthen partnerships with institutions such as the Department of Health and promoted shared solutions to student wellness challenges.”

She added that hosting the event underscored the UFS’s leadership in campus health and allowed other institutions to learn from its initiatives. Discussions and collaborations at the conference enhanced awareness campaigns and reinforced a collective commitment to student well-being.

Looking ahead, Johnson believes the insights gained will shape the future of Kovsie Health. “Exploring new health technologies and expanding student-centred health initiatives are among our top priorities,” she concluded. “The knowledge shared at this conference will undoubtedly influence how we evolve our services to meet the needs of our students more effectively.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept